Fast Brain Tumor Research
March 18, 2015
Brain tumor experts at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center have launched a revolutionary fast-track approach to cancer research. In partnership with The Ben & Catherine Ivy Foundation, the Translational Genomics Research Institute (TGen) and the Barbara Ann Karmanos Cancer Institute, the “Phase 0 Trials,” shorten the evaluation of drug therapies for brain tumors from an average of five years to only six months. Dr. Nader Sanai, director of the Barrow Brain Tumor Research Center, and Dr. Michael Berens, TGen’s Deputy Director for Research Resources, will discuss the new research method.